000 01210 a2200349 4500
005 20250513200730.0
264 0 _c20000202
008 200002s 0 0 pol d
022 _a0028-3843
040 _aNLM
_beng
_cNLM
100 1 _aGeppert, A
245 0 0 _a[TNF-alpha and soluble TNF receptor p55 in patients wtih multiple sclerosis].
_h[electronic resource]
260 _bNeurologia i neurochirurgia polska
_c
300 _a807-14 p.
_bdigital
500 _aPublication Type: Comparative Study; English Abstract; Journal Article
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aBiomarkers
650 0 4 _aBrain
_xpathology
650 0 4 _aChronic Disease
650 0 4 _aDisease Progression
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMethylprednisolone
_xtherapeutic use
650 0 4 _aMultiple Sclerosis
_xdiagnosis
650 0 4 _aReceptors, Tumor Necrosis Factor
_ximmunology
650 0 4 _aRecurrence
650 0 4 _aSeverity of Illness Index
650 0 4 _aTime Factors
650 0 4 _aTumor Necrosis Factor-alpha
_ximmunology
700 1 _aLosy, J
773 0 _tNeurologia i neurochirurgia polska
_gvol. 33
_gno. 4
_gp. 807-14
999 _c10567815
_d10567815